Form 4 for IMVT Immunovant, Inc.
Accepted 2025-12-12 00:00:00 ET · period of report 2025-12-12 · accession 0001140361-25-045409 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-12 | 2025-12-12 | IMVT | Roivant Sciences Ltd. | Dir, 10% | P - Purchase | $21.00 | +16.67M | 113.32M | +17% | +$350.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 par value per share | 2025-12-12 | P | A | 16,666,666 | $21.00 | 113,317,007 | D | — | — |